Find therapies in clinical trials near you – page 289

Study on Setrusumab for Patients with Osteogenesis Imperfecta (Brittle Bone Disease)

Study on Setrusumab for Patients with Osteogenesis Imperfecta (Brittle Bone Disease)

Study of ACP-204 for Treating Psychosis in Adults with Alzheimer's Disease

Study of ACP-204 for Treating Psychosis in Adults with Alzheimer's Disease

Study on Lisocabtagene Maraleucel for Adults with Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma

Study on Lisocabtagene Maraleucel for Adults with Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma

Study on the Safety and Effects of ATL001 and Pembrolizumab in Adults with Advanced Non-Small Cell Lung Cancer

Study on the Safety and Effects of ATL001 and Pembrolizumab in Adults with Advanced Non-Small Cell Lung Cancer

Study on Long-Term Use of Spesolimab for Patients with Hidradenitis Suppurativa Who Completed a Previous Spesolimab Study

Study on Long-Term Use of Spesolimab for Patients with Hidradenitis Suppurativa Who Completed a Previous Spesolimab Study

Study of Tarlatamab for Patients with Limited-Stage Small-Cell Lung Cancer After Chemoradiotherapy

Study of Tarlatamab for Patients with Limited-Stage Small-Cell Lung Cancer After Chemoradiotherapy

Study of Ibrutinib and Rituximab for Patients with Untreated Marginal Zone Lymphoma

Study of Ibrutinib and Rituximab for Patients with Untreated Marginal Zone Lymphoma

Study on the Safety and Effectiveness of mRNA-3927 for Patients with Propionic Acidemia

Study on the Safety and Effectiveness of mRNA-3927 for Patients with Propionic Acidemia

Study on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease

Study on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease

Study of Dazostinag and Pembrolizumab for Adults with Advanced or Metastatic Solid Tumors

Study of Dazostinag and Pembrolizumab for Adults with Advanced or Metastatic Solid Tumors

Study of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations

Study of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations

Study on the Effects of Acalabrutinib in Patients with Relapsed or Refractory Mantle Cell Lymphoma